The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbott, J. R.
Right arrow Articles by Brown, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbott, J. R.
Right arrow Articles by Brown, W. C.
Right arrowPubmed/NCBI databases
*Nucleotide*Protein
*Substance via MeSH
The Journal of Immunology, 2005, 174: 6702-6715.
Copyright © 2005 by The American Association of Immunologists

Rapid and Long-Term Disappearance of CD4+ T Lymphocyte Responses Specific for Anaplasma Marginale Major Surface Protein-2 (MSP2) in MSP2 Vaccinates following Challenge with Live A. marginale1

Jeffrey R. Abbott*, Guy H. Palmer*, Kimberly A. Kegerreis*, Peter F. Hetrick*, Chris J. Howard{dagger}, Jayne C. Hope{dagger} and Wendy C. Brown2,*

* Program in Vector-Borne Disease, Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164; and {dagger} Compton Laboratory, Institute of Animal Health, Compton, Newbury, United Kingdom

In humans and ruminants infected with Anaplasma, the major surface protein 2 (MSP2) is immunodominant. Numerous CD4+ T cell epitopes in the hypervariable and conserved regions of MSP2 contribute to this immunodominance. Antigenic variation in MSP2 occurs throughout acute and persistent infection, and sequentially emerging variants are thought to be controlled by variant-specific Ab. This study tested the hypothesis that challenge of cattle with Anaplasma marginale expressing MSP2 variants to which the animals had been immunized, would stimulate variant epitope-specific recall CD4+ T cell and IgG responses and organism clearance. MSP2-specific T lymphocyte responses, determined by IFN-{gamma} ELISPOT and proliferation assays, were strong before and for 3 wk postchallenge. Surprisingly, these responses became undetectable by the peak of rickettsemia, composed predominantly of organisms expressing the same MSP2 variants used for immunization. Immune responsiveness remained insignificant during subsequent persistent A. marginale infection up to 1 year. The suppressed response was specific for A. marginale, as responses to Clostridium vaccine Ag were consistently observed. CD4+CD25+ T cells and cytokines IL-10 and TGF-{beta}1 did not increase after challenge. Furthermore, a suppressive effect of nonresponding cells was not observed. Lymphocyte proliferation and viability were lost in vitro in the presence of physiologically relevant numbers of A. marginale organisms. These results suggest that loss of memory T cell responses following A. marginale infection is due to a mechanism other than induction of T regulatory cells, such as peripheral deletion of MSP2-specific T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Han, J. Norimine, G. H. Palmer, W. Mwangi, K. K. Lahmers, and W. C. Brown
Rapid Deletion of Antigen-Specific CD4+ T Cells following Infection Represents a Strategy of Immune Evasion and Persistence for Anaplasma marginale
J. Immunol., December 1, 2008; 181(11): 7759 - 7769.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Macmillan, J. Norimine, K. A. Brayton, G. H. Palmer, and W. C. Brown
Physical Linkage of Naturally Complexed Bacterial Outer Membrane Proteins Enhances Immunogenicity
Infect. Immun., March 1, 2008; 76(3): 1223 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Zhuang, J. E. Futse, W. C. Brown, K. A. Brayton, and G. H. Palmer
Maintenance of Antibody to Pathogen Epitopes Generated by Segmental Gene Conversion Is Highly Dynamic during Long-Term Persistent Infection
Infect. Immun., November 1, 2007; 75(11): 5185 - 5190.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Ge and Y. Rikihisa
Surface-Exposed Proteins of Ehrlichia chaffeensis
Infect. Immun., August 1, 2007; 75(8): 3833 - 3841.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. E. Lopez, G. H. Palmer, K. A. Brayton, M. J. Dark, S. E. Leach, and W. C. Brown
Immunogenicity of Anaplasma marginale Type IV Secretion System Proteins in a Protective Outer Membrane Vaccine
Infect. Immun., May 1, 2007; 75(5): 2333 - 2342.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. K. Lahmers, J. F. Hedges, M. A. Jutila, M. Deng, M. S. Abrahamsen, and W. C. Brown
Comparative gene expression by WC1+ {gamma}{delta} and CD4+ {alpha}{beta} T lymphocytes, which respond to Anaplasma marginale, demonstrates higher expression of chemokines and other myeloid cell-associated genes by WC1+ {gamma}{delta} T cells.
J. Leukoc. Biol., October 1, 2006; 80(4): 939 - 952.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
H. Macmillan, K. A. Brayton, G. H. Palmer, T. C. McGuire, G. Munske, W. F. Siems, and W. C. Brown
Analysis of the Anaplasma marginale Major Surface Protein 1 Complex Protein Composition by Tandem Mass Spectrometry
J. Bacteriol., July 1, 2006; 188(13): 4983 - 4991.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. E. Lopez, W. F. Siems, G. H. Palmer, K. A. Brayton, T. C. McGuire, J. Norimine, and W. C. Brown
Identification of Novel Antigenic Proteins in a Complex Anaplasma marginale Outer Membrane Immunogen by Mass Spectrometry and Genomic Mapping
Infect. Immun., December 1, 2005; 73(12): 8109 - 8118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.